Triglyceride-lowering drug does not affect plaque in arteries at one year in patients with elevated triglycerides: Study

Despite experiencing significant reductions in triglycerides, patients with triglycerides over 150 mg/dL and a high risk of atherosclerosis did not experience any significant change in the amount of non-calcified plaque in their coronary arteries after taking the triglyceride-lowering drug olezarsen, in a one-year sub-study presented at the American College of Cardiology’s Annual Scientific Session (ACC.26).

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup